Paratek Pharmaceuticals I... (PRTK)
NASDAQ: PRTK
· Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM
Paratek Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 38.06M | 29.21M | 72.63M | 27.84M | 27.55M | 22.76M | 29.3M | 21.44M | 55.41M | 14.81M |
Cost of Revenue | 4.37M | 6.24M | 10.31M | 4.37M | 4.88M | 3.49M | 4.72M | 4.29M | 9.78M | 2.75M |
Gross Profit | 33.69M | 22.96M | 62.31M | 23.47M | 22.68M | 19.27M | 24.58M | 17.15M | 45.63M | 12.06M |
Operating Income | -9.41M | -15.8M | -2.84M | -16.49M | -13.17M | -13.71M | -27.28M | -13.72M | 14.09M | -14.22M |
Interest Income | 252K | 221K | 327K | 186K | 133K | 107K | 5K | 25K | 11K | 25K |
Pretax Income | -14.5M | -20.08M | -7.1M | -20.88M | -17.62M | -17.91M | -31.65M | -18.2M | 9.72M | -18.35M |
Net Income | -14.55M | -20.14M | -7.16M | -25.27M | -22.07M | -17.91M | -32.25M | -18.2M | 9.72M | -18.35M |
Selling & General & Admin | 36.26M | 33.49M | 53.81M | 33.85M | 30.34M | 27.6M | 43.98M | 25.95M | 27.11M | 22.36M |
Research & Development | 8.77M | 7.31M | 14.27M | 8.49M | 7.59M | 7.48M | 10.38M | 7.92M | 6.52M | 5.54M |
Other Expenses | -56K | -2.03M | -2.93M | -2.37M | -2.08M | 175K | 12K | -143K | -39K | 157K |
Operating Expenses | 43.1M | 38.77M | 65.15M | 39.96M | 35.84M | 32.98M | 51.86M | 30.86M | 31.54M | 26.28M |
Interest Expense | 5.29M | 4.48M | 4.56M | 4.54M | 4.55M | 4.48M | 4.39M | 4.37M | 4.34M | 4.31M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 47.47M | 45.01M | 75.46M | 44.34M | 40.72M | 36.48M | 56.58M | 35.15M | 41.32M | 29.04M |
Income Tax Expense | 51K | 61K | 57K | 4.39M | 4.45M | n/a | 5M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 57.28M | 56.9M | 54.39M | 55.17M | 53.02M | 52.15M | 50.63M | 49.21M | 47.12M | 46.66M |
Shares Outstanding (Diluted) | 57.28M | 56.9M | 54.39M | 55.17M | 53.02M | 52.15M | 50.63M | 49.21M | 48.95M | 46.66M |
EPS (Basic) | -0.25 | -0.35 | -0.13 | -0.46 | -0.42 | -0.34 | -0.64 | -0.37 | 0.20 | -0.39 |
EPS (Diluted) | -0.25 | -0.35 | -0.13 | -0.46 | -0.42 | -0.34 | -0.64 | -0.37 | 0.20 | -0.39 |
EBITDA | -9.17M | -15.56M | -2.46M | -16.21M | -12.94M | -13.29M | -27.19M | -13.75M | 14.18M | -13.93M |
EBIT | -9.21M | -15.61M | -2.54M | -16.34M | -13.07M | -13.43M | -27.26M | -13.84M | 14.06M | -14.04M |
Depreciation & Amortization | 46K | 246K | 381K | 276K | 226K | 144K | 78K | 88K | 115K | 110K |